{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T15:00:19Z","timestamp":1780758019502,"version":"3.54.1"},"reference-count":56,"publisher":"Tsinghua University Press","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.26599\/1671-5411.2025.05.006","type":"journal-article","created":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T06:50:21Z","timestamp":1750834221000},"page":"477-496","source":"Crossref","is-referenced-by-count":2,"title":["Chinese guideline for the clinical application of noninvasive imaging technology in accessing cancer therapy-related cardiovascular toxicity"],"prefix":"10.26599","volume":"22","author":[{"given":"Mei","family":"ZHANG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dian-Fu","family":"LI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"PU","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"11138","reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1002\/ejhf.1957","article-title":"Role of cardiovascular imaging in cancer patients receiving cardiotoxic therapies: a position statement on behalf of the Heart Failure Association (HFA), the European Association of Cardiovascular Imaging (EACVI) and the Cardio-Oncology Council of the European Society of Cardiology (ESC)","volume":"22","author":"J Celutkiene","year":"2020","unstructured":"J Celutkiene. Role of cardiovascular imaging in cancer patients receiving cardiotoxic therapies: a position statement on behalf of the Heart Failure Association (HFA), the European Association of Cardiovascular Imaging (EACVI) and the Cardio-Oncology Council of the European Society of Cardiology (ESC). 2020, 22: 1504-1524.","journal-title":"Eur J Heart Fail"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"4229","DOI":"10.1093\/eurheartj\/ehac244","article-title":"2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)","volume":"43","author":"A R Lyon","year":"2022","unstructured":"A R Lyon. 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS). 2022, 43: 4229-4361.","journal-title":"Eur Heart J"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1002\/ejhf.654","article-title":"2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC)","volume":"19","author":"JL Zamorano","year":"2017","unstructured":"JL Zamorano. 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC). 2017, 19: 9-42.","journal-title":"Eur J Heart Fail"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s12968-019-0559-y","article-title":"Echocardiography and cardiovascular magnetic resonance based evaluation of myocardial strain and relationship with late gadolinium enhancement","volume":"21","author":"J Erley","year":"2019","unstructured":"J Erley. Echocardiography and cardiovascular magnetic resonance based evaluation of myocardial strain and relationship with late gadolinium enhancement. 2019, 21: 46.","journal-title":"J Cardiovasc Magn Reson"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/j.jcmg.2023.01.022","article-title":"Myocardial tissue-level characteristics of adults with metabolically healthy oesity","volume":"16","author":"H Zhao","year":"2023","unstructured":"H Zhao. Myocardial tissue-level characteristics of adults with metabolically healthy oesity. 2023, 16: 889-901.","journal-title":"JACC Cardiovasc Imaging"},{"issue":"5","key":"ref8","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1016\/j.cgh.2021.08.035","article-title":"Morphological, functional, and tissue characterization of silent myocardial involvement in patients with primary biliary cholangitis","volume":"20","author":"P Jiang","year":"2022","unstructured":"P Jiang. Morphological, functional, and tissue characterization of silent myocardial involvement in patients with primary biliary cholangitis. 2022, 20(5): 1112-1121. e4.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1021937","DOI":"10.3389\/fcvm.2023.1021937","article-title":"Protocol for pyrotinib cardiac safety in patients with HER2-positive early or locally advanced breast cancer-The EARLY-MYO-BC study","volume":"10","author":"Y Chai","year":"2023","unstructured":"Y Chai. Protocol for pyrotinib cardiac safety in patients with HER2-positive early or locally advanced breast cancer-The EARLY-MYO-BC study. 2023, 10: 1021937.","journal-title":"Front Cardiovasc Med"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1007\/s12350-019-01655-6","article-title":"Nuclear cardio-oncology: from its foundation to its future","volume":"27","author":"MG Kahanda","year":"2020","unstructured":"MG Kahanda. Nuclear cardio-oncology: from its foundation to its future. 2020, 27: 511-518.","journal-title":"J Nucl Cardiol"},{"issue":"Suppl D","key":"ref11","doi-asserted-by":"publisher","first-page":"D370","DOI":"10.1093\/eurheartj\/sux019","article-title":"ANMCO\/AIOM\/AICO consensus document on clinical and management pathways of cardio-oncology: executive summary","volume":"19","author":"L Tarantini","year":"2017","unstructured":"L Tarantini. ANMCO\/AIOM\/AICO consensus document on clinical and management pathways of cardio-oncology: executive summary. 2017, 19(Suppl D): D370-D379.","journal-title":"Eur Heart J"},{"key":"ref12","first-page":"133","article-title":"Relationship between coronary flow reserve by CZT SPECT and invasive coronary fractional flow reserve and its potential clinical value","volume":"43","author":"F Zhang","year":"2023","unstructured":"F Zhang. Relationship between coronary flow reserve by CZT SPECT and invasive coronary fractional flow reserve and its potential clinical value. 2023, 43: 133-138.","journal-title":"Chin J Nucl Med Mol Imaging"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"691893","DOI":"10.3389\/fmed.2021.691893","article-title":"Myocardial flow reserve measurement during CZT-SPECT perfusion imaging for coronary artery disease screening: correlation with clinical findings and invasive coronary angiography-the CFR-OR study","volume":"8","author":"M Bailly","year":"2021","unstructured":"M Bailly. Myocardial flow reserve measurement during CZT-SPECT perfusion imaging for coronary artery disease screening: correlation with clinical findings and invasive coronary angiography-the CFR-OR study. 2021, 8: 691893.","journal-title":"Front Med (Lausanne)"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"e533","DOI":"10.1161\/CIR.0000000000000945","article-title":"2020 AHA\/ACC Guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: executive summary: a report of the American College of Cardiology\/American Heart Association Joint Committee on clinical practice guidelines","volume":"142","author":"S R Ommen","year":"2020","unstructured":"S R Ommen. 2020 AHA\/ACC Guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: executive summary: a report of the American College of Cardiology\/American Heart Association Joint Committee on clinical practice guidelines. 2020, 142: e533-e557.","journal-title":"Circulation"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1093\/eurheartj\/ehz425","article-title":"2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes","volume":"41","author":"J Knuuti","year":"2020","unstructured":"J Knuuti. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. 2020, 41: 407-477.","journal-title":"Eur Heart J"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"e004560","DOI":"10.1161\/CIRCHEARTFAILURE.117.004560","article-title":"Left ventricular mass change after anthracycline chemotherapy","volume":"11","author":"JH Jordan","year":"2018","unstructured":"JH Jordan. Left ventricular mass change after anthracycline chemotherapy. 2018, 11: e004560.","journal-title":"Circ Heart Fail"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"S624","DOI":"10.1002\/ccd.28718","article-title":"Novel application of quantitative flow ratio for predicting microvascular dysfunction after ST-segment-elevation myocardial infarction","volume":"95","author":"X Sheng","year":"2020","unstructured":"X Sheng. Novel application of quantitative flow ratio for predicting microvascular dysfunction after ST-segment-elevation myocardial infarction. 2020, 95: S624-S632.","journal-title":"Catheter Cardiovasc Interv"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.jacc.2018.10.056","article-title":"Comparison of coronary computed tomography angiography, fractional flow reserve, and perfusion imaging for ischemia diagnosis","volume":"73","author":"RS Driessen","year":"2019","unstructured":"RS Driessen. Comparison of coronary computed tomography angiography, fractional flow reserve, and perfusion imaging for ischemia diagnosis. 2019, 73: 161-173.","journal-title":"J Am Coll Cardiol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1093\/eurheartj\/ehab674","article-title":"Defining cardiovascular toxicities of cancer therapies: an International Cardio-Oncology Society (IC-OS) consensus statement","volume":"43","author":"J Herrmann","year":"2022","unstructured":"J Herrmann. Defining cardiovascular toxicities of cancer therapies: an International Cardio-Oncology Society (IC-OS) consensus statement. 2022, 43: 280-299.","journal-title":"Eur Heart J"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"3158","DOI":"10.1016\/j.jacc.2018.09.072","article-title":"Cardiovascular magnetic resonance in nonischemic myocardial inflammation: Expert Recommendations","volume":"72","author":"VM Ferreira","year":"2018","unstructured":"VM Ferreira. Cardiovascular magnetic resonance in nonischemic myocardial inflammation: Expert Recommendations. 2018, 72: 3158-3176.","journal-title":"J Am Coll Cardiol"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1093\/eurheartj\/ehaa051","article-title":"Cardiovascular magnetic resonance in immune checkpoint inhibitor-associated myocarditis","volume":"41","author":"L Zhang","year":"2020","unstructured":"L Zhang. Cardiovascular magnetic resonance in immune checkpoint inhibitor-associated myocarditis. 2020, 41: 1733-1743.","journal-title":"Eur Heart J"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmg.2018.04.028","author":"","unstructured":"","journal-title":"null"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mds293","author":"","unstructured":"","journal-title":"null"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.4559","author":"","unstructured":"","journal-title":"null"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.3390\/cancers14051234","article-title":"Radiotherapy is associated with an accelerated risk of carotid atherosclerosis in patients with nasopharyngeal carcinoma: a nine-year prospective follow-up study","volume":"14","author":"CH Lu","year":"2022","unstructured":"CH Lu. Radiotherapy is associated with an accelerated risk of carotid atherosclerosis in patients with nasopharyngeal carcinoma: a nine-year prospective follow-up study. 2022, 14: 1234.","journal-title":"Cancers (Basel)"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"624057","DOI":"10.3389\/fonc.2021.624057","article-title":"Cardiac surveillance for early detection of late subclinical cardiac dysfunction in childhood cancer survivors after anthracycline therapy","volume":"11","author":"R Sofia","year":"2021","unstructured":"R Sofia. Cardiac surveillance for early detection of late subclinical cardiac dysfunction in childhood cancer survivors after anthracycline therapy. 2021, 11: 624057.","journal-title":"Front Oncol"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"2876","DOI":"10.1200\/JCO.2011.40.3584","article-title":"Screening adult survivors of childhood cancer for cardiomyopathy: comparison of echocardiography and cardiac magnetic resonance imaging","volume":"30","author":"GT Armstrong","year":"2012","unstructured":"GT Armstrong. Screening adult survivors of childhood cancer for cardiomyopathy: comparison of echocardiography and cardiac magnetic resonance imaging. 2012, 30: 2876-2884.","journal-title":"J Clin Oncol"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/1532-429X-15-66","article-title":"Understanding cardiovascular injury after treatment for cancer: an overview of current uses and future directions of cardiovascular magnetic resonance","volume":"15","author":"S Vasu","year":"2013","unstructured":"S Vasu. Understanding cardiovascular injury after treatment for cancer: an overview of current uses and future directions of cardiovascular magnetic resonance. 2013, 15: 66.","journal-title":"J Cardiovasc Magn Reson"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1111\/echo.14252","article-title":"Use of echocardiography to monitor myocardial damage during anthracycline chemotherapy","volume":"36","author":"Y Anqi","year":"2019","unstructured":"Y Anqi. Use of echocardiography to monitor myocardial damage during anthracycline chemotherapy. 2019, 36: 495-502.","journal-title":"Echocardiography"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"728215","DOI":"10.3389\/fcvm.2021.728215","article-title":"The utility of advanced cardiovascular imaging in cancer patients-when, why, how, and the latest developments","volume":"8","author":"C Yu","year":"2021","unstructured":"C Yu. The utility of advanced cardiovascular imaging in cancer patients-when, why, how, and the latest developments. 2021, 8: 728215.","journal-title":"Front Cardiovasc Med"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1016\/j.jcmg.2018.03.025","article-title":"Contemporary role of echocardiography for clinical decision making in patients during and after cancer therapy","volume":"11","author":"J Liu","year":"2018","unstructured":"J Liu. Contemporary role of echocardiography for clinical decision making in patients during and after cancer therapy. 2018, 11: 1122-1131.","journal-title":"JACC Cardiovasc Imaging"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1007\/s00392-019-01556-1","article-title":"Three-dimensional speckle-tracking echocardiography for the global and regional assessments of left ventricle myocardial deformation in breast cancer patients treated with anthracyclines","volume":"109","author":"M Coutinho Cruz","year":"2020","unstructured":"M Coutinho Cruz. Three-dimensional speckle-tracking echocardiography for the global and regional assessments of left ventricle myocardial deformation in breast cancer patients treated with anthracyclines. 2020, 109: 673-684.","journal-title":"Clin Res Cardiol"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1002\/clc.22872","article-title":"Left atrial volume in patients with HER2-positive breast cancer: One step further to predict trastuzumab-related cardiotoxicity","volume":"41","author":"C Bergamini","year":"2018","unstructured":"C Bergamini. Left atrial volume in patients with HER2-positive breast cancer: One step further to predict trastuzumab-related cardiotoxicity. 2018, 41: 349-353.","journal-title":"Clin Cardiol"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1007\/s10741-020-09938-8","article-title":"Right ventricular involvement in cancer therapy-related cardiotoxicity: the emerging role of strain echocardiography","volume":"26","author":"K Keramida","year":"2021","unstructured":"K Keramida. Right ventricular involvement in cancer therapy-related cardiotoxicity: the emerging role of strain echocardiography. 2021, 26: 1189-1193.","journal-title":"Heart Fail Rev"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jaccao.2021.01.011","article-title":"BSE and BCOS Guideline for transthoracic echocardiographic assessment of adult cancer patients receiving anthracyclines and\/or trastuzumab","volume":"3","author":"R Dobson","year":"2021","unstructured":"R Dobson. BSE and BCOS Guideline for transthoracic echocardiographic assessment of adult cancer patients receiving anthracyclines and\/or trastuzumab. 2021, 3: 1-16.","journal-title":"JACC Cardio Oncol"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1093\/ehjci\/jew018","article-title":"Right ventricular function in long-term adult survivors of childhood lymphoma and acute lymphoblastic leukaemia","volume":"17","author":"JR Christiansen","year":"2016","unstructured":"JR Christiansen. Right ventricular function in long-term adult survivors of childhood lymphoma and acute lymphoblastic leukaemia. 2016, 17: 735-741.","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"190138","DOI":"10.1183\/16000617.0138-2019","article-title":"Emerging role of cardiovascular magnetic resonance imaging in the management of pulmonary hypertension","volume":"29","author":"SR Aryal","year":"2020","unstructured":"SR Aryal. Emerging role of cardiovascular magnetic resonance imaging in the management of pulmonary hypertension. 2020, 29: 190138.","journal-title":"Eur Respir Rev"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"100818","DOI":"10.1016\/j.cpcardiol.2021.100818","article-title":"Subclinical cardiotoxicity: the emerging role of myocardial work and other imaging techniques","volume":"46","author":"D Di Lisi","year":"2021","unstructured":"D Di Lisi. Subclinical cardiotoxicity: the emerging role of myocardial work and other imaging techniques. 2021, 46: 100818.","journal-title":"Curr Probl Cardiol"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1093\/ehjci\/jeu206","article-title":"Visual assessment vs. strain imaging for the detection of critical stenosis of the left anterior descending coronary artery in patients without a history of myocardial infarction","volume":"16","author":"I Stankovic","year":"2015","unstructured":"I Stankovic. Visual assessment vs. strain imaging for the detection of critical stenosis of the left anterior descending coronary artery in patients without a history of myocardial infarction. 2015, 16: 402-409.","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"e005102","DOI":"10.1161\/JAHA.116.005102","article-title":"Predictive value of dobutamine stress perfusion echocardiography in contemporary end-stage liver disease","volume":"6","author":"B Baibhav","year":"2017","unstructured":"B Baibhav. Predictive value of dobutamine stress perfusion echocardiography in contemporary end-stage liver disease. 2017, 6: e005102.","journal-title":"J Am Heart Assoc"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1093\/cvr\/cvab053","article-title":"Coronary microcirculation damage in anthracycline cardiotoxicity","volume":"118","author":"C Gal\u00e1n-Arriola","year":"2022","unstructured":"C Gal\u00e1n-Arriola. Coronary microcirculation damage in anthracycline cardiotoxicity. 2022, 118: 531-541.","journal-title":"Cardiovasc Res"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1016\/j.echo.2020.01.007","article-title":"Coronary flow velocity reserve reduction is associated with cardiovascular, cancer, and noncancer, non-cardiovascular mortality","volume":"33","author":"N Gaibazzi","year":"2020","unstructured":"N Gaibazzi. Coronary flow velocity reserve reduction is associated with cardiovascular, cancer, and noncancer, non-cardiovascular mortality. 2020, 33: 594-603.","journal-title":"J Am Soc Echocardiogr"},{"key":"ref44","first-page":"906","article-title":"Chinese expert consensus on the clinical appropriate use criteria of non-invasive cardiovascular imaging modalities","volume":"48","author":"of Cardiology Division of Cardiovascular Imaging Society","year":"2020","unstructured":"of Cardiology Division of Cardiovascular Imaging Society. Chinese expert consensus on the clinical appropriate use criteria of non-invasive cardiovascular imaging modalities. 2020, 48: 906-921.","journal-title":"Chin J Cardiol"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1093\/ehjci\/jeaa351","article-title":"Cardiac computed tomography in cardio-oncology: an update on recent clinical applications","volume":"22","author":"S Rosmini","year":"2021","unstructured":"S Rosmini. Cardiac computed tomography in cardio-oncology: an update on recent clinical applications. 2021, 22: 397-405.","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/j.jcmg.2020.09.034","article-title":"Long-term prognosis of patients with coronary microvascular disease using stress perfusion cardiac magnetic resonance","volume":"14","author":"W Zhou","year":"2021","unstructured":"W Zhou. Long-term prognosis of patients with coronary microvascular disease using stress perfusion cardiac magnetic resonance. 2021, 14: 602-611.","journal-title":"JACC Cardiovasc Imaging"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1093\/ehjci\/jeac177","article-title":"Prognostic implications of left ventricular torsion measured by feature-tracking cardiac magnetic resonance in patients with ST-elevation myocardial infarction","volume":"24","author":"W Lai","year":"2023","unstructured":"W Lai. Prognostic implications of left ventricular torsion measured by feature-tracking cardiac magnetic resonance in patients with ST-elevation myocardial infarction. 2023, 24: 785-795.","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1161\/CIRCIMAGING.112.000193","article-title":"Advanced cardiovascular magnetic resonance myocardial perfusion imaging: high-spatial resolution versus 3-dimensional whole-heart coverage","volume":"6","author":"M Motwani","year":"2013","unstructured":"M Motwani. Advanced cardiovascular magnetic resonance myocardial perfusion imaging: high-spatial resolution versus 3-dimensional whole-heart coverage. 2013, 6: 339-348.","journal-title":"Circ Cardiovasc Imaging"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1093\/ehjci\/jez219","article-title":"Imaging in ESC clinical guidelines: chronic coronary syndromes","volume":"20","author":"A Saraste","year":"2019","unstructured":"A Saraste. Imaging in ESC clinical guidelines: chronic coronary syndromes. 2019, 20: 1187-1197.","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1016\/j.amjmed.2021.03.011","article-title":"Myocardial perfusion and viability imaging in coronary artery disease: clinical value in diagnosis, prognosis, and therapeutic guidance","volume":"134","author":"DL Li","year":"2021","unstructured":"DL Li. Myocardial perfusion and viability imaging in coronary artery disease: clinical value in diagnosis, prognosis, and therapeutic guidance. 2021, 134: 968-975.","journal-title":"Am J Med"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1093\/ejcts\/ezac209","article-title":"2021 ESC\/EACTS Guidelines for the management of valvular heart disease","volume":"43","author":"A Vahanian","year":"2022","unstructured":"A Vahanian. 2021 ESC\/EACTS Guidelines for the management of valvular heart disease. 2022, 43: 561-632.","journal-title":"Eur Heart J"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s11864-019-0672-z","article-title":"Advanced imaging modalities to monitor for cardiotoxicity","volume":"20","author":"A Seraphim","year":"2019","unstructured":"A Seraphim. Advanced imaging modalities to monitor for cardiotoxicity. 2019, 20: 73.","journal-title":"Curr Treat Options Oncol"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s11886-019-1193-x","article-title":"Clinical utility of [(18)F]FDG-PET \/CT in pericardial disease","volume":"21","author":"MS Kim","year":"2019","unstructured":"MS Kim. Clinical utility of [(18)F]FDG-PET \/CT in pericardial disease. 2019, 21: 107.","journal-title":"Curr Cardiol Rep"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"3618","DOI":"10.1093\/eurheartj\/ehac237","article-title":"2022 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension","volume":"43","author":"M Humbert","year":"2022","unstructured":"M Humbert. 2022 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. 2022, 43: 3618-3731.","journal-title":"Eur Heart J"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1093\/eurheartj\/ehv317","article-title":"2015 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT)","volume":"37","author":"N Galie","year":"2016","unstructured":"N Galie. 2015 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). 2016, 37: 67-119.","journal-title":"Eur Heart J"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"3226","DOI":"10.1182\/bloodadvances.2018024828","article-title":"American Society of Hematology 2018 guidelines for management of venous thromboembolism: diagnosis of venous thromboembolism","volume":"2","author":"W Lim","year":"2018","unstructured":"W Lim. American Society of Hematology 2018 guidelines for management of venous thromboembolism: diagnosis of venous thromboembolism. 2018, 2: 3226-3256.","journal-title":"Blood Adv"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1007\/s00405-020-06301-3","article-title":"Screening for irradiation vasculopathy by intima-media thickness sonography in head and neck cancer patients","volume":"278","author":"D Str\u00fcder","year":"2021","unstructured":"D Str\u00fcder. Screening for irradiation vasculopathy by intima-media thickness sonography in head and neck cancer patients. 2021, 278: 2017-2026.","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1161\/HYPERTENSIONAHA.116.08749","article-title":"Aortic arch pulse wave velocity assessed by magnetic resonance imaging as a predictor of incident cardiovascular events: The MESA (Multi-Ethnic Study of Atherosclerosis)","volume":"70","author":"Y Ohyama","year":"2017","unstructured":"Y Ohyama. Aortic arch pulse wave velocity assessed by magnetic resonance imaging as a predictor of incident cardiovascular events: The MESA (Multi-Ethnic Study of Atherosclerosis). 2017, 70: 524-530.","journal-title":"Hypertension"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s12968-015-0174-5","article-title":"4D flow cardiovascular magnetic resonance consensus statement","volume":"17","author":"P Dyverfeldt","year":"2015","unstructured":"P Dyverfeldt. 4D flow cardiovascular magnetic resonance consensus statement. 2015, 17: 72.","journal-title":"J Cardiovasc Magn Reson"}],"container-title":["Journal of Geriatric Cardiology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T06:50:22Z","timestamp":1750834222000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.sciopen.com\/article\/10.26599\/1671-5411.2025.05.006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":56,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"URL":"https:\/\/doi.org\/10.26599\/1671-5411.2025.05.006","relation":{},"ISSN":["1671-5411"],"issn-type":[{"value":"1671-5411","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]}}}